Silence of circPLK1 inhibits NSCLC progression by regulating the miR-1294/SLC16A9 axis

Chuankui Li1, Yifan Yang1, Qicai Li1

  • 1Department of Thoracic Surgery, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, PR China.

Molecular Immunology
|December 24, 2025
PubMed
Abstract

Insights

Circular RNA polo-like kinase 1 (circPLK1) promotes non-small cell lung cancer (NSCLC) progression. Silencing circPLK1 inhibits NSCLC cell proliferation, migration, and invasion via the miR-1294/SLC16A9 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
  • Circular RNAs (circRNAs) are implicated in cancer progression, but their specific roles require elucidation.
  • The function of circRNA polo-like kinase 1 (circPLK1) in NSCLC pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the role and mechanism of circPLK1 in non-small cell lung cancer (NSCLC).
  • To determine the regulatory relationship between circPLK1, miR-1294, and SLC16A9 in NSCLC.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure circPLK1 expression.
  • Bioinformatics analysis to predict miRNA-target interactions.
  • Cellular assays (CCK-8, colony formation, flow cytometry, Transwell) to assess proliferation, viability, apoptosis, migration, and invasion.
  • Western blotting for protein analysis and xenograft models for in vivo validation.

Main Results:

  • circPLK1 expression was significantly upregulated in NSCLC cells.
  • Silencing circPLK1 inhibited NSCLC cell viability, proliferation, migration, and invasion, while promoting apoptosis.
  • circPLK1 functions as a molecular sponge for miR-1294, enhancing SLC16A9 expression.
  • Knockdown of circPLK1 suppressed tumor growth in vivo by modulating the miR-1294/SLC16A9 axis.

Conclusions:

  • circPLK1 plays a crucial role in promoting NSCLC progression.
  • circPLK1 inhibition suppresses NSCLC proliferation, migration, and invasion through the miR-1294/SLC16A9 pathway.
  • circPLK1 represents a potential therapeutic target for NSCLC treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K